Rilmenidine is an isourea. Rilmenidine has been used in trials studying the treatment of Hypertension and Chronic Kidney Disease. RILMENIDINE is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987 and has 1 investigational indication. It is grouped under the following drug class(es): Alpha-2 agonists. Its therapeutic use is listed as antihypertensives and cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Oxaminozoline, Hyperium, Albarel and Tocris-0790. Its PubChem CID is 68712.
Rilmenidine
| CAS No | 54187-04-1 |
|---|---|
| Molecular Formula | C10H16N2O |
| Molecular Weight | 180.25 g/mol |
| Synonyms | N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Rilmenidine is an isourea. Rilmenidine has been used in trials studying the treatment of Hypertension and Chronic Kidney Disease. RILMENIDINE is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987 and has 1 investigational indication.
The listed CAS number is 54187-04-1.
The listed molecular formula is C10H16N2O.
The listed molecular weight is 180.25 g/mol.
N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine.
The source lists Oxaminozoline, Hyperium, Albarel and Tocris-0790.